114 related articles for article (PubMed ID: 4038309)
1. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
[TBL] [Abstract][Full Text] [Related]
2. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.
Clough ER; Audibert FM; Barnwell JW; Schlesinger DH; Arnon R; Chedid LA
Infect Immun; 1985 Jun; 48(3):839-42. PubMed ID: 3997250
[TBL] [Abstract][Full Text] [Related]
3. Role of muramyl peptides for the enhancement of synthetic vaccines.
Chedid L; Audibert F; Jolivet M
Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
[TBL] [Abstract][Full Text] [Related]
4. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
5. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.
Lise LD; Mazier D; Jolivet M; Audibert F; Chedid L; Schlesinger D
Infect Immun; 1987 Nov; 55(11):2658-61. PubMed ID: 2444539
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine.
Telzak E; Wolff SM; Dinarello CA; Conlon T; el Kholy A; Bahr GM; Choay JP; Morin A; Chedid L
J Infect Dis; 1986 Mar; 153(3):628-33. PubMed ID: 3950444
[No Abstract] [Full Text] [Related]
7. A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
Schutze MP; LeClerc C; Jolivet M; Deriaud E; Audibert F; Chang CC; Chedid L
Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):84-90. PubMed ID: 2445212
[TBL] [Abstract][Full Text] [Related]
8. Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.
Przewlocki G; Audibert F; Jolivet M; Chedid L; Kent SB; Neurath AR
Biochem Biophys Res Commun; 1986 Oct; 140(2):557-64. PubMed ID: 3778467
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
Lew AM; Anders RF; Edwards SJ; Langford CJ
Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
[TBL] [Abstract][Full Text] [Related]
10. [Use of muramyl dipeptides in models of synthetic vaccines].
Audibert F
Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
[TBL] [Abstract][Full Text] [Related]
11. Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.
Jolivet ME; Audibert FM; Gras-Masse H; Tartar AL; Schlesinger DH; Wirtz R; Chedid LA
Infect Immun; 1987 Jun; 55(6):1498-502. PubMed ID: 3553005
[TBL] [Abstract][Full Text] [Related]
12. Anti-cholera response elicited by a completely synthetic antigen with built-in adjuvanticity administered in aqueous solution.
Jacob CO; Arnon R; Sela M
Immunol Lett; 1986 Nov; 14(1):43-8. PubMed ID: 3804383
[TBL] [Abstract][Full Text] [Related]
13. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S
Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429
[TBL] [Abstract][Full Text] [Related]
14. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys.
Siddiqui WA; Tam LQ; Kan SC; Kramer KJ; Case SE; Palmer KL; Yamaga KM; Hui GS
Infect Immun; 1986 Apr; 52(1):314-8. PubMed ID: 3514459
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.
Leclerc CD; Audibert FM; Chedid LA; Deriaud EJ; Masihi NK; Lederer E
Infect Immun; 1984 Mar; 43(3):870-5. PubMed ID: 6698611
[TBL] [Abstract][Full Text] [Related]
17. Effect of priming with carrier on response to conjugate vaccine.
Di John D; Wasserman SS; Torres JR; Cortesia MJ; Murillo J; Losonsky GA; Herrington DA; Stürcher D; Levine MM
Lancet; 1989 Dec; 2(8677):1415-8. PubMed ID: 2480499
[TBL] [Abstract][Full Text] [Related]
18. Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvant.
Jolivet M; Audibert F; Beachey EH; Tartar A; Gras-Masse H; Chedid L
Biochem Biophys Res Commun; 1983 Dec; 117(2):359-66. PubMed ID: 6197973
[TBL] [Abstract][Full Text] [Related]
19. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
20. Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators.
Davis D; Gregoriadis G
Immunology; 1989 Oct; 68(2):277-82. PubMed ID: 2509329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
